# Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults

> **NCT01634191** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT01634191
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-01
- **Primary completion:** 2012-03-01
- **Final completion:** 2012-04-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01634191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01634191, "Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01634191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*